MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.390
+0.020 (1.46%)
At close: Aug 21, 2026, 4:00 PM EDT
1.380
-0.010 (-0.72%)
After-hours: Aug 21, 2026, 7:55 PM EDT
MediciNova Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, MediciNova stock has a consensus rating of "Strong Buy" and an average price target of $9.00. The average 1-year stock price forecast is 547.48% higher than the current stock price, while the lowest is $6.00 (+331.65%) and the highest is $11 (+691.37%).
Price Target: $9.00 (+547.48%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MediciNova stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $6 | Buy | Maintains | $6 | +331.65% | Aug 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +619.42% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
187.00K
from 409.66K
Decreased by -54.35%
Revenue Next Year
500.00K
from 187.00K
Increased by 167.38%
EPS This Year
-0.28
from -0.24
EPS Next Year
-0.45
from -0.28
EPS and Forward PE are based on non-GAAP adjusted numbers.